3rd Quarter - Report
TARPLIN, DOWNS & YOUNG, LLC for NOVARTIS
Client
Income
$60,000
Expenses
—
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Federal budget issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| PARICK BRAERTON CARROLL | Leg Asst. Rep. Ray LaHood, Leg Dir. Rep. Kevin Yoder, PSM Senate Appropriations Cmte. |
| RAISSA H DOWNS | Prin. Dep. Asst. Sec for Leg.-HHS; Dep. Asst. Sec. for Leg.-HSS; Staff Dir., Sub Cmte. on Employment, Sen. HELP Cmte. |
| PETER FISE | Health Counsel for Sen. Cmte on Finance, Health Counsel for Sen. Jeanne Shaheen, Staff Assistant for House Cmte on Oversight & Government Reform |
| LAURA FRIEDEL | Leg. Asst., Sen. Zell Miller, Leg. Dir., Sen. Richard Shelby, Clerk, Staff Dir., Sen. Appropriations Committee |
| CHARLOTTE SPEARS IVANCIC | Leg. Counsel, Sen. Jim DeMint; Health Counsel, Maj. Leader Bill Frist; Counsel and Budget Analyst, House Budget Cmte.; Asst. to the Speaker for Policy, Speaker John Boehner |
| MARGARET JOSEPH | CoS for Sen. Kyrsten Sinema, CoS for Rep. Kyrsten Sinema, CoS for Rep. Bobby Bright, CoS for Rep. Jim Matheson, Clerk for House Rules Cmte. |
| ELIZABETH T MURRAY | Senior Policy Advisor, Democratic Whip Steny Hoyer; Leg. Asst., Rep. Mike Thompson, Rep. Bob Matsui, and Sen. Bob Graham |
| EMILY H MURRY | Staff Dir., Sub. Cmte. on Helath, Ways and Means Cmte; Sr. Policy Adivsor, Maj. Leader McCarthy; Policy Advisor, Maj. Whip McCarthy; Prof. Staff, Republicans Study Cmte.; Leg. Aide, Rep. Ken Calvert; Leg. Asst., Rep. Tom Price |
| PAMELA SMITH | Leg. Dir., Sen. Tom Harkin; Dep. Staff Dir., Sen. HELP Cmte.; Staff Dir., Sen. HELP Cmte.; Counsel to Asst. AG, Civil Div., Dept. of Justice; Spec. Counsel, Ofc of Leg. Affairs, Dept. of Justice; Counsel and LA, Sen. Carol Moseley-Braun |
| JENNIFER B YOUNG | Asst. Sec. for Leg.- HHS; Dep. Asst. Sec for Leg. - HHS; Cmte. Staff, House Cmte. on Ways and Means; Cmte. Staff. Sen. Cmte. on Finance |
Health Issues HCR
MINI Act, IRA, affordability, pharmaceutical innovation, transparency, intellectual property, PBMs, pharmaceutical pricing issues, drug shortages, genetically targeted therapies, EPIC Act, supply chain, drug pricing and drug discount programs in federal programs, international drug reference pricing
| Lobbyist | Covered position, as disclosed |
|---|---|
| PARICK BRAERTON CARROLL | — |
| RAISSA H DOWNS | — |
| PETER FISE | — |
| LAURA FRIEDEL | — |
| CHARLOTTE SPEARS IVANCIC | — |
| MARGARET JOSEPH | — |
| ELIZABETH T MURRAY | — |
| EMILY H MURRY | — |
| PAMELA SMITH | — |
| JENNIFER B YOUNG | — |
Medicare/Medicaid MMM
bio pharmaceutical reimbursement issues, IRA
| Lobbyist | Covered position, as disclosed |
|---|---|
| PARICK BRAERTON CARROLL | — |
| RAISSA H DOWNS | — |
| PETER FISE | — |
| LAURA FRIEDEL | — |
| CHARLOTTE SPEARS IVANCIC | — |
| MARGARET JOSEPH | — |
| ELIZABETH T MURRAY | — |
| EMILY H MURRY | — |
| PAMELA SMITH | — |
| JENNIFER B YOUNG | — |
Trade (domestic/foreign) TRD
tariffs
| Lobbyist | Covered position, as disclosed |
|---|---|
| PARICK BRAERTON CARROLL | — |
| RAISSA H DOWNS | — |
| PETER FISE | — |
| LAURA FRIEDEL | — |
| CHARLOTTE SPEARS IVANCIC | — |
| MARGARET JOSEPH | — |
| ELIZABETH T MURRAY | — |
| EMILY H MURRY | — |
| PAMELA SMITH | — |
| JENNIFER B YOUNG | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.